about
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular CarcinomaY90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study.Hepatic imaging following intra-arterial embolotherapy.Types of Research Bias Encountered in IR.New Developments in Interventional Oncology: Liver Metastases From Colorectal Cancer.Single- versus Triple-Drug Chemoembolization for Hepatocellular Carcinoma: Comparing Outcomes by Toxicity, Imaging Response, and Survival.Comparison of the Adverse Event Profile of TheraSphere® with SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma: A Systematic Review.Long-Term Hepatotoxicity of Yttrium-90 Radioembolization as Treatment of Metastatic Neuroendocrine Tumor to the Liver.Independent Analysis of Albumin-Bilirubin Grade in a 765-Patient Cohort Treated with Transarterial Locoregional Therapy for Hepatocellular Carcinoma.Y90 Radioembolization for Locally Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis: Long-Term Outcomes in a 185-Patient Cohort.Institutional Decision to Adopt Y90 as Primary Treatment for HCC Informed by a 1,000-patient 15-year Experience.Radioembolization for hepatocellular carcinoma: Statistical confirmation of improved survival in responders by landmark analyses.Pictorial essay: imaging findings following Y90 radiation segmentectomy for hepatocellular carcinoma.Survival Analysis of Advanced HCC Treated with Radioembolization: Comparing Impact of Clinical Performance Status Versus Vascular Invasion/Metastases.Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization.Commentary on: "Occupational radiation exposure of medical staff performing ⁹⁰Y-loaded microsphere radioembolization".The Utility of Unilobar Technetium-99m Macroaggregated Albumin to Predict Pulmonary Toxicity In Bilobar Hepatocellular Carcinoma prior to Yttrium-90 Radioembolization.Same-day 90Y radioembolization: implementing a new treatment paradigm.Angiogenic Response following Radioembolization: Results from a Randomized Pilot Study of Yttrium-90 with or without Sorafenib.Indicators of Lung Shunt Fraction Determined by Technetium-99 m Macroaggregated Albumin in Patients with Hepatocellular Carcinoma.Noncirrhotic complete obliterative portal vein thrombosis: Novel management using trans-splenic transjugular intrahepatic portosystemic shunt with portal vein recanalization.Fluoroscopic Radiation Exposure in Chemoembolization and Radioembolization: Results from a Prospective Randomized Study.Outcomes of Surgical Resection after Radioembolization for Hepatocellular CarcinomaReplyProstate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption StudyLiver Transplantation Following Yttrium-90 Radioembolization: 15-year Experience in 207-Patient Cohort
P50
Q26753089-AA332BD2-DEA6-4DBA-8D0B-7E895D291344Q28314897-E10BCCAC-709A-4991-BA31-CF386D5136BFQ38658822-21553FFB-3F77-430B-9434-96F2785B0ECEQ38716483-A819A8F8-E888-49FA-BDBE-8CC357242673Q38762954-CB4A96B5-0F1F-4F01-B82D-CC398480AB49Q38792621-AF542431-7A41-439C-A1D6-A68207EE4FA3Q38803399-CAE902D6-CD9C-4CFE-8792-69A0BF749D51Q38936579-23C42BBF-C393-4B29-B68E-55086BA00534Q39412258-185F3B2A-6611-4674-A50C-97D176055D5DQ40821228-FD44A9BF-715E-4D7E-B414-94BB54AD915EQ47347973-97516E29-85F2-452C-8AAF-E7E46A79001CQ47384456-77468EFA-CD3F-409D-AF11-78AAD875895DQ48193183-6277C73B-D4D1-40A8-87B2-75BDAC14676DQ48285755-2748C335-0923-4868-8F05-FC44B010380BQ50209684-FE7C63D0-67C5-41EE-A875-0175C0140123Q50550624-A318852C-1617-463A-99DF-07170AE7B849Q51535074-01F8393E-73B1-40D1-97B4-6908C6FD55E3Q51547661-51706DC9-969B-4DA6-8F66-CB973EA5C05CQ51697540-E196D457-9E1B-4E51-B71E-D881FC9F7D71Q51718385-D4D14E8A-E8DC-4AE7-9E7E-AF7979A34CE7Q52893237-1CD28B6B-4353-419B-BB6D-AC3A2ADA7EAAQ52986127-F285A4D6-CD8F-4BA1-8336-8153E9650ADFQ54530794-80887D44-AF9D-4D7E-8A06-492B551E3DABQ57148425-7679F810-4513-43A4-9732-15CD161210E2Q89071030-2CF0D626-47D8-49FB-8885-6A409BD08608Q90417129-80DAA89B-3CC3-4B55-B2A9-428D746AAD45Q94951977-00BF9518-E4A9-4874-9925-5801E3779BA9
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ahmed Gabr
@ast
Ahmed Gabr
@en
Ahmed Gabr
@es
Ahmed Gabr
@nl
Ahmed Gabr
@sl
type
label
Ahmed Gabr
@ast
Ahmed Gabr
@en
Ahmed Gabr
@es
Ahmed Gabr
@nl
Ahmed Gabr
@sl
prefLabel
Ahmed Gabr
@ast
Ahmed Gabr
@en
Ahmed Gabr
@es
Ahmed Gabr
@nl
Ahmed Gabr
@sl
P106
P1153
57103082700
P21
P31
P3835
ahmed-gabr4
P496
0000-0001-6636-0189